• Platform
  • Pipeline
    • Overview
    • Clinical Trial
  • Team
    • Leadership
    • Board of Directors
  • News
  • Careers

Kelonia Therapeutics Announces Upcoming Oral Presentation of Preclinical Data with First Details of iGPS™ Technology at ASGCT Annual Meeting

by rob@robmaguiredesigns.com | May 2, 2023 | Press Releases

Preclinical data demonstrate iGPS particles efficiently and specifically deliver CAR molecules to T cells in vivo for durable tumor clearance without need for lymphodepleting chemotherapy Company developing iGPS technology to provide potentially safe, efficacious,...

Kelonia Therapeutics Launches with $50 Million Series A Financing to Pioneer Precision Targeted Genetic Medicines

by brian@orrbitt.com | Apr 28, 2022 | Press Releases

In Vivo Gene Delivery Platform Will Dramatically Expand the Benefit and Reach of Genetic Medicines Founded and Led by Leading Experts in Immunology, Oncology, and Cell and Gene Therapy Strategic Collaborations with Leading Industry Partners Enable and Accelerate...
Next Entries »

Recent Posts

  • Lilly to acquire Kelonia Therapeutics to advance in vivo CAR-T cell therapies
  • Kelonia Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for KLN-1010, an in vivo BCMA CAR-T Therapy for Relapsed and Refractory Multiple Myeloma   
  • Kelonia Therapeutics Presents First-in-Human Data from Phase 1 inMMyCAR Study of KLN-1010 in vivo BCMA CAR-T Therapy at the American Society of Hematology (ASH) 2025 Annual Meeting  
  • Kelonia Therapeutics Announces Late-Breaking Oral Presentation of First-in-Human Data from in vivo BCMA CAR-T Therapy at the American Society of Hematology (ASH) 2025 Annual Meeting
  • Kelonia Therapeutics Enters into Strategic Collaboration with Johnson & Johnson to Advance in vivo CAR-T Therapies

Recent Comments

No comments to show.

Genetic Medicines for Every Patient.

  • Platform
  • Pipeline
    • Overview
    • Clinical Trial
  • Team
    • Leadership
    • Board of Directors
  • News
  • Careers




© 2025 KELONIA THERAPEUTICS, INC. ALL RIGHTS RESERVED.
PRIVACY POLICY. TERMS OF USE